Company Filing History:
Years Active: 2016
Title: Stephanie Guerro-Lagasse: Innovator in Cell Proliferation Inhibitors
Introduction
Stephanie Guerro-Lagasse is a prominent inventor based in Basel, Switzerland. She has made significant contributions to the field of biotechnology, particularly in the development of therapies for cell proliferative disorders. Her innovative work has led to the filing of a patent that showcases her expertise and dedication to advancing medical science.
Latest Patents
Stephanie holds a patent titled "Cell proliferation inhibitors and conjugates thereof." This patent discloses immunoconjugates that comprise an inhibitor of Eg5 linked to an antigen binding moiety, such as an antibody. These immunoconjugates are useful for treating cell proliferative disorders. The invention also includes novel inhibitors of Eg5 that can be utilized either alone or as part of an immunoconjugate. Furthermore, the patent provides pharmaceutical compositions that comprise these compounds and immunoconjugates, along with methods for their use in treating cell proliferation disorders. She has 1 patent to her name.
Career Highlights
Stephanie is currently employed at Novartis AG, a leading global healthcare company. Her role at Novartis allows her to work on cutting-edge research and development projects that aim to improve patient outcomes through innovative therapies.
Collaborations
Throughout her career, Stephanie has collaborated with notable colleagues, including Paul Andrew Barsanti and Sylvie Chamoin. These collaborations have further enriched her research and contributed to the advancement of her projects.
Conclusion
Stephanie Guerro-Lagasse is a trailblazer in the field of biotechnology, with a focus on developing innovative solutions for cell proliferation disorders. Her contributions through her patent and work at Novartis AG highlight her commitment to improving healthcare through scientific innovation.